Top Page
Brave Bison
(LSE:BBSN)
Brave Bison (BBSN) vs. iShares MSCI United Kingdom ETF (EWC)
Brave Bison Business Overview & Revenue Model
Brave Bison Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.05M | 32.83M | 35.70M | 31.65M | 21.66M | 14.49M |
| Gross Profit | 23.26M | 21.34M | 20.90M | 16.95M | 7.81M | 3.98M |
| EBITDA | 1.86M | 3.18M | 2.33M | 2.14M | 838.00K | -822.00K |
| Net Income | 1.19M | 2.26M | 3.39M | 2.08M | 458.00K | -2.03M |
Balance Sheet | ||||||
| Total Assets | 38.63M | 32.70M | 30.50M | 20.60M | 19.61M | 6.08M |
| Cash, Cash Equivalents and Short-Term Investments | 4.16M | 7.60M | 6.92M | 6.49M | 5.91M | 2.75M |
| Total Debt | 1.89M | 1.85M | 1.85M | 701.00K | 1.44M | 466.00K |
| Total Liabilities | 14.90M | 11.41M | 11.90M | 10.58M | 12.08M | 5.33M |
| Stockholders Equity | 23.72M | 21.29M | 18.59M | 10.02M | 7.53M | 760.00K |
Cash Flow | ||||||
| Free Cash Flow | -398.00K | 1.46M | 1.67M | 1.63M | 3.96M | -990.00K |
| Operating Cash Flow | -234.00K | 1.62M | 1.82M | 1.71M | 3.99M | -824.00K |
| Investing Cash Flow | -2.06M | -565.00K | -4.74M | -335.00K | -6.32M | -162.00K |
| Financing Cash Flow | -447.00K | -366.00K | 3.35M | -823.00K | 5.49M | -511.00K |
Brave Bison Technical Analysis
Brave Bison Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | £82.33M | 43.75 | 5.43% | 0.48% | 1.92% | -75.53% | |
61 Neutral | £115.02M | 38.46 | 89.29% | ― | 7.54% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
52 Neutral | £5.07M | -20.48 | -3.35% | ― | 20.71% | 96.18% | |
43 Neutral | £58.34M | -30.75 | ― | ― | -26.19% | 71.43% |
Brave Bison Corporate Events
Brave Bison has appointed Singer Capital Markets as a Joint Broker, working alongside Cavendish Capital Markets, to enhance its market presence and operational capabilities. This strategic move is expected to strengthen the company’s position in the marketing and technology industry, potentially benefiting stakeholders by expanding its reach and services.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £71.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison announced that a resolution proposed at their recent general meeting was not passed by shareholders, as it was voted down in a poll. This outcome reflects a significant decision by the shareholders, potentially impacting the company’s strategic direction and indicating a divergence in views between the management and its stakeholders.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £71.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison has announced a general meeting in response to a requisition notice from Lord Michael Ashcroft, proposing the appointment of Julia Robertson as a non-executive director. The Board recommends voting against this resolution, having consulted with shareholders and strategic partners, and received support from shareholders representing 51% of the company’s issued share capital.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £71.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison Group PLC has received a requisition notice from Lord Michael Ashcroft to hold a general meeting for the appointment of a new director to the Board. The Board plans to organize the meeting following statutory guidelines, advising shareholders to refrain from taking any action at this moment.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £71.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison Group PLC announced that its Executive Chairman, Oliver Green, and Chief Growth Officer, Theo Green, have exercised their put option rights under the 2021 Executive Long-Term Incentive Plan (LTIP), resulting in the issuance of 6,377,110 new ordinary shares. This move, representing 6.6% of the company’s existing share capital, is part of a strategic remuneration structure aimed at retaining and motivating key executives, reflecting a significant increase in shareholder value since the LTIP’s adoption.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £71.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison Group PLC has received a communication from representatives of Lord Michael Ashcroft expressing a desire to appoint a nominee Director to the Company’s Board. The Board is currently evaluating the situation and plans to consult with shareholders, with further updates to be provided as necessary.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £71.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison has acquired MTM London Limited, a strategy and insights consultancy, for an initial cash-and-share consideration of £6 million. This acquisition is expected to significantly enhance Brave Bison’s financial performance, increasing its pro-forma EBITDA to £9.4 million and net revenue to £44 million for FY25. The acquisition aligns with Brave Bison’s strategy to expand its market presence and capabilities, with MTM contributing positively to the company’s operations. The acquisition also positions Brave Bison to exceed market expectations for FY25 and FY26, supported by strong trading and new customer wins.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £64.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison Group PLC has reported a 19% increase in net revenue and a 6% rise in adjusted EBITDA for the first half of 2025, surpassing market expectations. The company has made five acquisitions, including the significant purchase of MiniMBA, and completed a £15.5 million fundraising. These strategic moves are expected to enhance Brave Bison’s competitive position and market reach, with future growth anticipated in FY25 and FY26. The acquisition of MiniMBA, a marketing skills and training platform, will form a new practice within the company, strengthening its position as a partner for future-focused brands.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £64.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison reported a 19% increase in net revenue and a 6% rise in adjusted EBITDA for the first half of 2025, surpassing market expectations. The company completed five acquisitions, including the significant purchase of MiniMBA, and raised £15.5 million through an oversubscribed fundraising. These strategic moves are expected to enhance Brave Bison’s competitive position and expand its market reach, particularly in marketing skills training. The acquisition of MiniMBA will form a new skills and capabilities practice, positioning Brave Bison as a key partner for future-focused brands.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £64.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison Group PLC has announced that it will release its unaudited interim results for the first half of 2025 on September 11. The company will also host a live investor presentation on September 15, open to current and potential shareholders, providing an opportunity for engagement and questions about the company’s performance and future prospects.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £64.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.